Skip to content

CANTER continues to build momentum in the fight against equine anthelmintic resistance

CANTER Core steering group minutes

The CANTER Core Steering Group met in June to review progress across a wide range of projects supporting the responsible use of anthelmintics and sustainable parasite control. The meeting highlighted the breadth of collaborative activity taking place across research, education, communications and guideline development, demonstrating CANTER’s continued commitment to tackling anthelmintic resistance through a coordinated, evidence based approach.

Recent months have seen the publication of two new guideline chapters, alongside a new myth buster resource on Strongylus vulgaris and guidance on the use of piperazine. Work is also nearing completion on a new series of CANTER podcasts, designed to make the Guidelines more accessible to a wider audience through an engaging new format. The Autumn Guideline review is already being planned, with opportunities to incorporate new evidence and practical resources that further support prescribers.

The Steering Group also received updates from its Research and Communications Subgroups. Research activity continues to focus on identifying knowledge gaps and strengthening collaboration, including support for a proposed European COST Action network that would bring together researchers working on sustainable equine parasite control. Meanwhile, the Communications Subgroup is developing a horse owner campaign to launch Spring 2026. It will feature a three step call to action and a suite of downloadable resources to help owners make informed decisions that reduce reliance on routine anthelmintic use.

Members also discussed opportunities to improve prescribing consistency through the development of a standard written prescription template, while recognising the importance of education in driving long term change. Encouragingly, the meeting also heard how CANTER Guidelines have already influenced updates to product information for some established equine anthelmintics, ensuring prescribing information better reflects current best practice.

Looking ahead, CANTER will continue expanding its educational resources, strengthening industry collaboration and promoting consistent, evidence based parasite control. Together, these initiatives support the shared goal of preserving the effectiveness of existing anthelmintics and safeguarding equine health for the future.